Ulhas Kamath, Deputy Managing Director of Jyothy Laboratories, told CNBC-TV18 that contrary to the market speculations, the company is not looking at acquiring the Indian assets of Henkel AG. “We have our own plans on organic growth and we are not looking at Henkel as an asset in our portfolio,” he asserts.